Arkema SA 2012 IR
The report outlines Arkema's financial and sustainability performance for the fiscal year 2012. Key highlights include the strategic acquisition of Hipro Polymers and Casda Biomaterials in China to expand its bio-sourced polyamides portfolio, alongside the divestment of its vinyl activities to focus on specialty chemicals. The company reported sales of 6.4 billion euros and an EBITDA of 996 million euros. In terms of sustainability, Arkema reduced its total recordable injury rate to 3.4 and continued its efforts to minimize its environmental footprint across its global operations.
Company: Arkema SA
Sector: Materials
Country: France
Year: 2012
Type: IR
Pages: 283
Back to company
Arkema SA
Reference Document
The report outlines Arkema's financial and sustainability performance for the fiscal year 2012. Key highlights include the strategic acquisition of Hipro Polymers and Casda Biomaterials in China to expand its bio-sourced polyamides portfolio, alongside the divestment of its vinyl activities to focus on specialty chemicals. The company reported sales of 6.4 billion euros and an EBITDA of 996 million euros. In terms of sustainability, Arkema reduced its total recordable injury rate to 3.4 and continued its efforts to minimize its environmental footprint across its global operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2012
Reporting Period
Jan 1, 2012 - Dec 31, 2012
Fiscal Year
2012
Published
Mar 27, 2013
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Employees